Autonomous Oxygen Titration

Uses

How it works

Dosage & preparation

Risks & contraindications

Comparisons

Evidence quality

Highlighted claims

• The O2matic PRO100 is a trend-based, closed-loop autonomous oxygen titration system approved in 32 countries, including the EU, Australia, and New Zealand, but not yet FDA-approved in the USA. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• The PRO100 is being evaluated in this trial under an FDA Investigational Device Exemption. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• In the usual care group, the PRO100 is attached in observation mode only, with autonomous titration disabled. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• In the intervention group, the PRO100 is programmed to an internal SpO₂ range of 92–94%, targeting 93%. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• Escalation beyond 15 L/min or evidence of advancing respiratory failure triggers removal from the autonomous system. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• Closed-loop autonomous oxygen titration systems continuously adjust oxygen flow in real time to keep SpO₂ within a clinician-specified range. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• Most prior evidence for autonomous titration concerns mechanically ventilated patients, but most oxygen-receiving inpatients breathe spontaneously. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol
• Preliminary clinical evidence showed the PRO100 reduced both hypoxemia and hyperoxemia in patients with COVID-19 pneumonia and in patients with COPD. — Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol